Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2766]
Articles [207]
Editorials [1]
Conferences [136]
elearning [13]
Induced cell suicide with p97 disruption
Induced cell suicide with p97 disruption
Last Month in Oncology with Dr. Bishal Gyawali: September 2016
Last Month in Oncology with Dr. Bishal Gyawali: September 2016
Blocking Ran protein reverses resistance of lung and breast cancers
Blocking Ran protein reverses resistance of lung and breast cancers
Triple-drug chemotherapy with topotecan helps preserve vision in retinoblastoma patients
Triple-drug chemotherapy with topotecan helps preserve vision in retinoblastoma patients
Cancer treatment as a double-edged sword
Cancer treatment as a double-edged sword
ESMO 2016: MEK inhibition in KRAS-mutant NSCLC did not improve survival
ESMO 2016: MEK inhibition in KRAS-mutant NSCLC did not improve survival
ESMO 2016: Significant survival gains from neoadjuvant chemo for high-risk soft tissue sarcoma
ESMO 2016: Significant survival gains from neoadjuvant chemo for high-risk soft tissue sarcoma
ESMO 2016: Custirsen shows no survival benefits in metastatic prostate cancer
ESMO 2016: Custirsen shows no survival benefits in metastatic prostate cancer
ESMO 2016: Nintedanib improves PFS but not OS in phase III trial of metastatic colorectal cancer
ESMO 2016: Nintedanib improves PFS but not OS in phase III trial of metastatic colorectal cancer
ESMO 2016: Greater patient selection may be needed for first line nivolumab to improve PFS in advanced lung cancer
ESMO 2016: Greater patient selection may be needed for first line nivolumab to improve PFS in advanced lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation